Clinical trial

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it…

NCT00310349 · University of Melbourne, Other · Unknown status

Key facts

NCT number NCT00310349
Title PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
Official title PneuMum: A Randomised Controlled Trial of Pneumococcal Polysaccharide Vaccination for Aboriginal and Torres Strait Islander Mothers to Protect Their Babies From Ear Disease
Lead sponsor University of Melbourne, Other
Collaborators National Health and Medical Research Council, Australia Menzies School of Health Research
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Middle Ear Effusion, Tympanic Membrane Perforation, Acute Otitis Media, Pneumococcal Infections
Intervention type Biological
Interventions 23 valent pneumococcal polysaccharide vaccine
Enrollment 210
Start date Mar 1, 2006
Completion Jan 1, 2009
First posted Apr 3, 2006
Last update posted Dec 13, 2007
Countries Australia

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies